{"DataElement":{"publicId":"4983474","version":"1","preferredName":"Adrenal Cortical Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Tumor T Stage","preferredDefinition":"Extent of the primary adrenal cortical cancer based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"4982832v1.0:4983378v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"4982832","version":"1","preferredName":"Adrenal Cortex Carcinoma Pathologic T Stage","preferredDefinition":"A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"3648745v1.0:2207099v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3648745","version":"1","preferredName":"Adrenal Cortex Carcinoma","preferredDefinition":"A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.","longName":"C9325","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cortical Carcinoma","conceptCode":"C9325","definition":"A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2697BF7-7C82-AC1F-E040-BB89AD43606F","latestVersionIndicator":"Yes","beginDate":"2013-01-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-03","modifiedBy":"ONEDATA","dateModified":"2013-01-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"1E23D7F2-30F9-E129-E050-BB89AD43047B","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"TAYLORT","dateModified":"2017-10-09","changeDescription":"10/9/17 tt transferred context; changed Reg Status to Qualified. Created per request by COG for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4983378","version":"1","preferredName":"Adrenal Cancer American Joint Committee on Cancer (AJCC) Edition 7 T Stage","preferredDefinition":"A finding about one or more characteristics of adrenal cancer, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"4983378v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T0","valueDescription":"Adrenal Cancer pT0 TNM Finding v7","ValueMeaning":{"publicId":"4983380","version":"1","preferredName":"Adrenal Cancer pT0 TNM Finding v7","longName":"4983380","preferredDefinition":"Adrenal cancer with no evidence of a primary tumor. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cancer pT0 TNM Finding v7","conceptCode":"C89400","definition":"Adrenal cancer with no evidence of a primary tumor. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2629DD-500C-838D-E050-BB89AD430258","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E2629DD-5025-838D-E050-BB89AD430258","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"T1","valueDescription":"Adrenal Cancer pT1 TNM Finding v7","ValueMeaning":{"publicId":"4983382","version":"1","preferredName":"Adrenal Cancer pT1 TNM Finding v7","longName":"4983382","preferredDefinition":"Adrenal cancer with tumor measuring 5 cm or less in greatest dimension, without extra-adrenal invasion. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cancer pT1 TNM Finding v7","conceptCode":"C89401","definition":"Adrenal cancer with tumor measuring 5 cm or less in greatest dimension, without extra-adrenal invasion. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2629DD-5032-838D-E050-BB89AD430258","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E2629DD-504B-838D-E050-BB89AD430258","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"T2","valueDescription":"Adrenal Cancer pT2 TNM Finding v7","ValueMeaning":{"publicId":"4983384","version":"1","preferredName":"Adrenal Cancer pT2 TNM Finding v7","longName":"4983384","preferredDefinition":"Adrenal cancer with tumor measuring more than 5 cm in greatest dimension without extra-adrenal invasion. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cancer pT2 TNM Finding v7","conceptCode":"C89402","definition":"Adrenal cancer with tumor measuring more than 5 cm in greatest dimension without extra-adrenal invasion. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2629DD-5058-838D-E050-BB89AD430258","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E2629DD-5071-838D-E050-BB89AD430258","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"T3","valueDescription":"Adrenal Cancer pT3 TNM Finding v7","ValueMeaning":{"publicId":"4983386","version":"1","preferredName":"Adrenal Cancer pT3 TNM Finding v7","longName":"4983386","preferredDefinition":"Adrenal cancer with tumor of any size with local invasion, without invasion of adjacent organs.  Adjacent organs include kidney, diaphragm, great vessels, pancreas, spleen, and liver. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cancer pT3 TNM Finding v7","conceptCode":"C89403","definition":"Adrenal cancer with tumor of any size with local invasion, without invasion of adjacent organs.  Adjacent organs include kidney, diaphragm, great vessels, pancreas, spleen, and liver. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2629DD-507E-838D-E050-BB89AD430258","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E2629DD-5097-838D-E050-BB89AD430258","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"T4","valueDescription":"Adrenal Cancer pT4 TNM Finding v7","ValueMeaning":{"publicId":"4983388","version":"1","preferredName":"Adrenal Cancer pT4 TNM Finding v7","longName":"4983388","preferredDefinition":"Adrenal cancer with tumor of any size, with invasion of adjacent organs.  Adjacent organs include kidney, diaphragm, great vessels, pancreas, spleen, and liver. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cancer pT4 TNM Finding v7","conceptCode":"C89404","definition":"Adrenal cancer with tumor of any size, with invasion of adjacent organs.  Adjacent organs include kidney, diaphragm, great vessels, pancreas, spleen, and liver. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2629DD-50A4-838D-E050-BB89AD430258","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E2629DD-50BD-838D-E050-BB89AD430258","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"},{"value":"TX","valueDescription":"Adrenal Cancer pTX TNM Finding v7","ValueMeaning":{"publicId":"4983390","version":"1","preferredName":"Adrenal Cancer pTX TNM Finding v7","longName":"4983390","preferredDefinition":"Adrenal cancer in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cancer pTX TNM Finding v7","conceptCode":"C89399","definition":"Adrenal cancer in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2629DD-50CA-838D-E050-BB89AD430258","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1E2629DD-50E3-838D-E050-BB89AD430258","beginDate":"2012-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4983377","version":"1","preferredName":"Adrenal Cancer TNM Finding v7 American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A finding about one or more characteristics of adrenal cancer, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C89396:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cancer TNM Finding v7","conceptCode":"C89396","definition":"A finding about one or more characteristics of adrenal cancer, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2629DD-4FE0-838D-E050-BB89AD430258","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"ONEDATA","dateModified":"2015-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E2629DD-4FF1-838D-E050-BB89AD430258","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"COOPERM","dateModified":"2015-09-22","changeDescription":"Created per request by COG for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"10000511","version":"1","longName":"Adrenal Gland","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"4982440","version":"1","longName":"Adrenal Gland","context":"NCI Standards"},{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic T Stage","type":"Preferred Question Text","description":"Pathologic T Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"1E2629DD-52D4-838D-E050-BB89AD430258","latestVersionIndicator":"Yes","beginDate":"2015-08-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-25","modifiedBy":"COOPERM","dateModified":"2017-02-21","changeDescription":"Created by COG request for their APEC14B1 study in Rave. mc 8/25/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}